
Assessing Pharma’s constraints, opportunities, and investment options in global health R&D: An analysis of SEC 10-K filings
Launched in 2016, the Brookings Private Sector Global Health R&D Project seeks to identify financial incentives to spur private sector investment in medications for developing countries in Asia and Africa.